SecBot SecBot
8-K ·Filed Nov 3, 2026

ADUS

Addus HomeCare Corp
BULLISH
Impact 6/10
Horizonimmediate Processed13d 8h ago SEC0001437749-26-034669
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The AccentCare acquisition, if closed, would expand revenue base by ~19% and add scale in key states. Monitor regulatory approval timeline and integration progress. Q3 results show consistent organic growth and margin expansion.

DirectionBullish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$127.94
T+0 close · Nov 3, 2026 · via day close
Latest settled
−1.92%
T+5 · $125.49 · next T+20 in 16d
Vs SPY
−1.00%
α at T+5
Latest observation
−2.46%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $127.94entry
  2. T+1 · 12d ago −0.88%α +3.53% · $126.81
  3. T+5 · 6d ago −1.92%α −1.00% · $125.49
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Addus HomeCare reported Q3 2026 revenue of $387.7M (+7.0% YoY) and adjusted EPS of $1.83 (+17.3% YoY), exceeding consensus estimates of $388.7M and $1.79. The company also announced a definitive agreement to acquire AccentCare's personal care division for ~$275M, adding ~$280M in annualized revenue.

Key Financial Metrics

EPS (Adj.)
$1.83
est $1.79 · +2.2% · GAAP: $1.54
Revenue
$387.7M
est $388.7M · -0.3% · +7.0% YoY
Rating
beat
Gross Margin
32.1%

Key Facts

  • Q3 2026 net service revenue $387.7M, up 7.0% YoY from $362.3M
  • GAAP net income $28.6M ($1.54/diluted share) vs $22.8M ($1.24) YoY
  • Adjusted net income per diluted share $1.83, up 17.3% YoY from $1.56
  • Adjusted EBITDA $51.2M, up 13.5% YoY from $45.1M
  • Operating cash flow $40.9M in Q3 2026
  • Definitive agreement to acquire AccentCare personal care division for ~$275M, adding ~$280M annualized revenue
  • Personal care segment revenue $301.0M (77.6% of total), organic growth 6.9%
  • Hospice segment revenue $69.0M, organic ADC growth 4.3%
  • Home health segment returned to organic revenue growth of 2.5%
  • Cash $98.5M, bank debt $24.3M, $617.8M available under revolver as of Sep 30, 2026

Financial Impact

Revenue $387.7M, GAAP EPS $1.54, adjusted EPS $1.83, adjusted EBITDA $51.2M, operating cash flow $40.9M

revenueepsebitdacash flow

Segment Breakdown

SegmentRevenueGrowth
Personal Care$301.0M+9.2%
Hospice$69.0M+0.2%
Home Health$17.7M+0.4%

Risk Factors

  • AccentCare acquisition requires regulatory approvals and customary closing conditions
  • Home health segment revenue still negative on a YTD basis (-2.3% organic)
  • Hospice organic revenue growth of 4.1% slowed from prior year's 19.0%
  • State reimbursement rate changes could impact personal care margins

Market Snapshot

Exchange
Nasdaq
Sector
Services-Home Health Care Services
Analyst Consensus
80% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-034669
Document: adus20261103_8k.htm0001437749-26-034669
Document: 0001437749-26-034669-index-headers.html0001437749-26-034669
Document: 0001437749-26-034669-index.html0001437749-26-034669
Document: 0001437749-26-034669.txt0001437749-26-034669
8-K Data (Synthetic)0001437749-26-034669

US Market Status

Market Closed · Opens in 8h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026